These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 33708124)

  • 1. Targeting Neurological Manifestations of Coronaviruses by Candidate Phytochemicals: A Mechanistic Approach.
    Fakhri S; Piri S; Majnooni MB; Farzaei MH; Echeverría J
    Front Pharmacol; 2020; 11():621099. PubMed ID: 33708124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
    Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E
    Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Malekmohammad K; Rafieian-Kopaei M
    Curr Pharm Des; 2021; 27(38):3996-4007. PubMed ID: 34225607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological manifestations of COVID-19 and other coronaviruses: A systematic review.
    Correia AO; Feitosa PWG; Moreira JLS; Nogueira SÁR; Fonseca RB; Nobre MEP
    Neurol Psychiatry Brain Res; 2020 Sep; 37():27-32. PubMed ID: 32834527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
    Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
    J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phytochemicals: Potential Therapeutic Interventions Against Coronavirus-Associated Lung Injury.
    Majnooni MB; Fakhri S; Shokoohinia Y; Kiyani N; Stage K; Mohammadi P; Gravandi MM; Farzaei MH; Echeverría J
    Front Pharmacol; 2020; 11():588467. PubMed ID: 33658931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights.
    Divani AA; Andalib S; Di Napoli M; Lattanzi S; Hussain MS; Biller J; McCullough LD; Azarpazhooh MR; Seletska A; Mayer SA; Torbey M
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104941. PubMed ID: 32689643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain Renin-Angiotensin System: From Physiology to Pathology in Neuronal Complications Induced by SARS-CoV-2.
    Ahmadi S; Khaledi S
    Anal Cell Pathol (Amst); 2023; 2023():8883492. PubMed ID: 37575318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic.
    Sharifian-Dorche M; Huot P; Osherov M; Wen D; Saveriano A; Giacomini PS; Antel JP; Mowla A
    J Neurol Sci; 2020 Oct; 417():117085. PubMed ID: 32871412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Update on Promising Agents against COVID-19: Secondary Metabolites and Mechanistic Aspects.
    Jamshidnia M; Sewell RDE; Rafieian-Kopaei M
    Curr Pharm Des; 2022; 28(29):2415-2425. PubMed ID: 35899955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries.
    Román GC; Spencer PS; Reis J; Buguet A; Faris MEA; Katrak SM; Láinez M; Medina MT; Meshram C; Mizusawa H; Öztürk S; Wasay M;
    J Neurol Sci; 2020 Jul; 414():116884. PubMed ID: 32464367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronavirus Infection-Associated Cell Death Signaling and Potential Therapeutic Targets.
    Yapasert R; Khaw-On P; Banjerdpongchai R
    Molecules; 2021 Dec; 26(24):. PubMed ID: 34946543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological manifestations and comorbidity associated with COVID-19: an overview.
    Kumar M; Thakur AK
    Neurol Sci; 2020 Dec; 41(12):3409-3418. PubMed ID: 33052573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders?
    Murta V; Villarreal A; Ramos AJ
    ASN Neuro; 2020; 12():1759091420954960. PubMed ID: 32878468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronavirus Disease 2019 (COVID-19) From the Point of View of Neurologists: Observation of Neurological Findings and Symptoms During the Combat Against a Pandemic.
    Özdağ Acarli AN; Samanci B; Ekizoğlu E; Çakar A; Şirin NG; Gündüz T; Parman Y; Baykan B
    Noro Psikiyatr Ars; 2020 Jun; 57(2):154-159. PubMed ID: 32550783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological Sequelae of COVID-19.
    Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ
    J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders.
    Tyagi K; Rai P; Gautam A; Kaur H; Kapoor S; Suttee A; Jaiswal PK; Sharma A; Singh G; Barnwal RP
    Eur J Med Res; 2023 Aug; 28(1):307. PubMed ID: 37649125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the Nervous System: Implications of COVID-19 in Neurodegeneration.
    Rodriguez M; Soler Y; Perry M; Reynolds JL; El-Hage N
    Front Neurol; 2020; 11():583459. PubMed ID: 33304309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological manifestations of coronavirus infections: role of angiotensin-converting enzyme 2 in COVID-19.
    Parsamanesh N; Pezeshgi A; Hemmati M; Jameshorani M; Saboory E
    Int J Neurosci; 2022 Sep; 132(9):917-924. PubMed ID: 33175635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.